KYNB 10-Q: SEC filing

Kyntra Bio (formerly FibroGen)

Filed with the SEC on · accession 0001193125-26-463519

KYNB filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -7.0% by the first close after the filing.

Summary of the filing

Kyntra Bio (formerly FibroGen) filed its Q3 2026 Form 10-Q, reporting quarterly financial results including revenue from Astellas collaboration and drug product sales, along with ongoing clinical and corporate activities.

Key details

Collaboration partnerAstellas Pharma
Share purchase agreement counterpartyAstraZeneca

How KYNB stock reacted

Close before

$3.44

Nov 13, 2026

First close after

-6.98%

$3.20

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for KYNB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KYNB?

Click here

Frequently asked questions

What did KYNB file with the SEC on Nov 16, 2026?

KYNB filed a 10-Q (SEC filing). Kyntra Bio (formerly FibroGen) filed its Q3 2026 Form 10-Q, reporting quarterly financial results including revenue from Astellas collaboration and drug product sales, along with ongoing clinical and corporate activities.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did KYNB stock react to this filing?

KYNB closed at $3.44 before the filing and $3.20 on Nov 16, 2026 (-6.98%).

Other KYNB SEC filings

Get alerts when KYNB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days